Walleye Capital’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,458
Closed -$599K 2777
2023
Q1
$599K Buy
+9,458
New +$599K 0.01% 927